4-Amino-6-methyl-2H-pyridazin-3-one, 95.0%, 500mg

2-([1,3]DIOXOLO[4,5-G]ISOQUINOLIN-8-YL)ACETIC ACID, 95.0%, 250mg

2,2,2-Trichloro-1-(4-iodo-1h-pyrrol-2-yl)ethan-1-one, 95%, 250mg

C8 alkyne dCTP, min. 95%, 100 mM in water, 10 µl, plastic package.

5-Amino-1,4-dioxo-1,4-dihydronaphthalene-2,3-dicarbonitrile, 97%, 1g

4-Bromo-3-formylbenzonitrile, 95.0%, 1g

4,7-Dibromobenzo[c][1,2,5]selenadiazole, 97%, 100mg

Methanol 60%, 60%, for synthesis, 5 l, plastic packaging.

N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acrylamide, 95.0%, 1g

(S)-2-AMINO-4-FLUORO-4-METHYLPENTANOIC ACID, 95.0%, 1g

2,4,5-Trimethyl-1h-imidazole, 95%, 1g

(2E)-1-(3-chlorophenyl)-3-(4-ethylphenyl)prop-2-en-1-one, 95.0%, 10g

[4-(ethylsulfonyl)phenyl]amine, 95.0%, 25g